Neuromyelitis optica spectrum disorders with non opticospinal manifestations as initial symptoms: a long-term observational study

نویسندگان

چکیده

Abstract Background Early stage neuromyelitis optica spectrum disorders (NMOSD) with non-opticospinal manifestations as initial symptoms are easily misdiagnosed; however, data on the full symptom profile limited. Moreover, clinical characteristics and long-term outcomes of these patients remain unknown. We sought to analyze characteristics, imaging features, NMOSD symptoms. Methods retrospectively included relevant from our center. Clinical, demographic, magnetic resonance imaging, treatment, outcome were compared according vs. opticospinal Results identified 43 (9.13 %) among 471 NMOSD. Of these, 88.37 % developed optic neuritis/myelitis during an average follow-up period 6.33 years. All brain/brainstem Most associated brain lesions reversible. These had a younger onset age ( P < 0.001), lower serum aquaporin-4 (AQP4) antibody titers = 0.030), Expanded Disability Status Scale (EDSS) score at 0.001) 0.041) than In addition, EDSS scores reached 3.0 (indicating moderate disability) later in 0.028). Conclusions Patients have age, AQP4 titers, better outcomes.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate

BACKGROUND To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD). METHODS We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a positive NMO-IgG testing, who were treated with methotrexate. A paired sample 2 tailed t test was ...

متن کامل

Neuromyelitis optica without typical opticospinal phenotype.

Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system (CNS) characterized by severe optic neuritis (ON) and acute myelitis (AM). NMO differs in many respects from multiple sclerosis (MS). NMO-IgG is an autoantibody exclusively detected in the sera of NMO, and is directed against aquaporin-4 (AQP4), a water channel richly expressed on astrocytes in the CNS. In most ...

متن کامل

Neuromyelitis Optica Spectrum Disorders: Diagnosis and Treatment

The last decade has witnessed rapid developments in the clinical understanding and scienti fi c foundati on of neuromyeliti s opti ca (NMO). The landmark events were the late 19th century report by Devic and Gault describing the associati on of severe acute transverse myeliti s and opti c neuriti s and the late 20th century discovery that the syndrome was associated with a specifi c autoanti bo...

متن کامل

Neuromyelitis optica spectrum disorders without and with autoimmune diseases

BACKGROUND Neuromyelitis optica spectrum disorder (NMOSD) can coexist with non-organ-specific or organ-specific autoimmune diseases. The aim of this study was to investigate and compare the features between NMOSD without and with autoimmune diseases, and NMOSD with non-organ-specific and organ-specific autoimmune diseases. METHODS One hundred and fifty five NMOSD patients without autoimmune d...

متن کامل

A Rare Presentation of Neuromyelitis Optica Spectrum Disorders

Neuromyelitis optica spectrum disorders (NMOSDs) are a set of demyelinating disorders that primarily target the optic nerves and the spinal cord. Previously thought to be a subset of multiple sclerosis (MS), now is recognized as a distinct entity. We present a 59-year-old female patient who was admitted for acute upper and lower extremity weakness. The patient had woken up from sleep with sudde...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMC Neurology

سال: 2021

ISSN: ['1471-2377']

DOI: https://doi.org/10.1186/s12883-021-02059-1